JEANA WHITACRE: Open Payments
NPI 1326461500 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 25 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $507 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Novo Nordisk Inc | 4 | $69 |
| Dexcom, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, FARXIGA, Dexcom G6 Transmitter, Ozempic, Kerendia, ZEPBOUND, JARDIANCE, REPATHA.
Industry payments across MS — which companies pay providers there.
